These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2723114)

  • 1. Influence of demographic factors on cyclosporine pharmacokinetics in adult uremic patients.
    Grevel J; Reynolds KL; Rutzky LP; Kahan BD
    J Clin Pharmacol; 1989 Mar; 29(3):261-6. PubMed ID: 2723114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine pharmacokinetics in uremic patients: influence of different assay methods.
    Reynolds KL; Grevel J; Gibbons SY; Welsh MS; Rutzky LP; Kahan BD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):462-5. PubMed ID: 3363649
    [No Abstract]   [Full Text] [Related]  

  • 3. Demographic factors influencing cyclosporine pharmacokinetic parameters in patients with uremia: racial differences in bioavailability.
    Lindholm A; Welsh M; Alton C; Kahan BD
    Clin Pharmacol Ther; 1992 Oct; 52(4):359-71. PubMed ID: 1330397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood cyclosporine pharmacokinetics in patients undergoing marrow transplantation. Influence of age, obesity, and hematocrit.
    Yee GC; McGuire TR; Gmur DJ; Lennon TP; Deeg HJ
    Transplantation; 1988 Sep; 46(3):399-402. PubMed ID: 3047931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of obesity on cyclosporine pharmacokinetics in uremic patients.
    Flechner SM; Kolbeinsson MC; Lum B; Tam J; Moran T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1446-8. PubMed ID: 2652464
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacokinetics of cyclosporine A in uremic patients.
    Lindberg A; Odlind B; Tufveson G; Lindström B; Gabrielsson J
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):144-52. PubMed ID: 3787709
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine kinetics in healthy volunteers.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ; Gray JA; Van Thiel DH; Sanghvi A; Rosenthal JT
    J Clin Pharmacol; 1987 Mar; 27(3):243-8. PubMed ID: 3680581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
    Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is elimination of cyclosporine in bile dependent on liver graft function and biliary drainage?
    Jain AB; Elias E; Gunson BK; Buckels JA; McDowell B; Hillis A; McMaster P
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):516-22. PubMed ID: 3284099
    [No Abstract]   [Full Text] [Related]  

  • 10. Small-bowel length and the dose of cyclosporine in children after liver transplantation.
    Whitington PF; Emond JC; Whitington SH; Broelsch CE; Baker AL
    N Engl J Med; 1990 Mar; 322(11):733-8. PubMed ID: 2308602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics of cyclosporine and its metabolites in patients undergoing kidney transplantation].
    Silva Junior HT; Pereira AB; Ajzen H; Bueno V; Pestana JO
    Rev Assoc Med Bras (1992); 1994; 40(3):159-71. PubMed ID: 7787866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of body weight on cyclosporine pharmacokinetics in renal transplant recipients.
    Flechner SM; Kolbeinsson ME; Tam J; Lum B
    Transplantation; 1989 May; 47(5):806-10. PubMed ID: 2655218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses.
    Karlsson MO; Lindberg-Freijs A
    J Pharmacokinet Biopharm; 1990 Aug; 18(4):293-311. PubMed ID: 2231321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and clinical tolerance of intravenous and oral cyclosporine in the immediate postoperative period.
    Morse GD; Holdsworth MT; Venuto RC; Gerbasi J; Walshe JJ
    Clin Pharmacol Ther; 1988 Dec; 44(6):654-64. PubMed ID: 3058372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99mTc-HEPIDA hepatic clearance as a diagnostic tool: usefulness of plasma and hepatic clearance for assessment of hepatic parenchyma performance.
    Frieske I; Surma MJ; Bieńkiewicz M; Białkowska-Warzecha J; Liniecki J; Kuydowicz J; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2003; 6(1):23-8. PubMed ID: 14600929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cyclosporine A in patients with nephrotic syndrome.
    Vernillet L; Moulin B; Dadoun C; Le Bigot JF; Fillastre JP
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):529-35. PubMed ID: 3363653
    [No Abstract]   [Full Text] [Related]  

  • 17. Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay.
    Kahan BD; Kramer WG; Wideman C; Flechner SM; Lorber MI; Van Buren CT
    Transplantation; 1986 Apr; 41(4):459-64. PubMed ID: 3515645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cyclosporine clearance in marrow transplant recipients: age-related variation.
    Yee GC; Mills G; Schaffer R; Lennon TP; Kennedy MS; Deeg HJ
    J Clin Pharmacol; 1986; 26(8):658-61. PubMed ID: 3540031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia.
    Aumente D; Buelga DS; Lukas JC; Gomez P; Torres A; García MJ
    Clin Pharmacokinet; 2006; 45(12):1227-38. PubMed ID: 17112298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine kinetics in renal transplantation.
    Ptachcinski RJ; Venkataramanan R; Rosenthal JT; Burckart GJ; Taylor RJ; Hakala TR
    Clin Pharmacol Ther; 1985 Sep; 38(3):296-300. PubMed ID: 3896612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.